A detailed history of Oversea Chinese Banking Corp LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Oversea Chinese Banking Corp LTD holds 8,917 shares of ABBV stock, worth $1.57 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,917
Previous 4,700 89.72%
Holding current value
$1.57 Million
Previous $806,000 118.36%
% of portfolio
0.05%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $690,913 - $840,574
4,217 Added 89.72%
8,917 $1.76 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $297,196 - $347,059
1,920 Added 69.06%
4,700 $806,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $1.09 Million - $1.24 Million
-6,827 Reduced 71.06%
2,780 $506,000
Q4 2023

May 21, 2024

BUY
$137.6 - $154.97 $939,395 - $1.06 Million
6,827 Added 245.58%
9,607 $1.49 Million
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $143,792 - $161,943
1,045 Added 12.21%
9,607 $1.49 Million
Q3 2023

Apr 29, 2024

SELL
$133.59 - $154.65 $139,601 - $161,609
-1,045 Reduced 10.88%
8,562 $1.28 Million
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $858,582 - $993,935
6,427 Added 301.03%
8,562 $1.28 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $685,209 - $852,697
-5,171 Reduced 70.78%
2,135 $287,000
Q1 2023

Sep 15, 2023

BUY
$144.61 - $166.54 $1.1 Million - $1.26 Million
7,574 Added 200.58%
11,350 $1.81 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $510,473 - $587,886
3,530 Added 93.49%
7,306 $1.16 Million
Q4 2022

Sep 15, 2023

BUY
$138.31 - $165.87 $226,966 - $272,192
1,641 Added 76.86%
3,776 $610,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $522,258 - $626,325
3,776 New
3,776 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Oversea Chinese Banking Corp LTD Portfolio

Follow Oversea Chinese Banking Corp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.